Pacemaker and tricuspid valve health: long-term outcomes
Part of Heart & circulation clinical trials.
This study looks at how pacemakers and similar heart devices affect the tricuspid valve over time and whether that leads to worse health outcomes. It may help you understand if your device is causing long-term changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have an implantable electronic heart device, like a pacemaker or defibrillator.
- Your device was implanted at Qianfoshan Hospital between 2015 and 2025.
- You did not have severe tricuspid valve leakage or surgery on that valve before getting the device.
- You do not have severe heart valve disease, a congenital heart defect, or a serious irregular heartbeat.
- Your pacemaker is not a single-chamber type (it has more than one lead).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a new pacemaker or defibrillator lead may affect the tricuspid valve (the valve between the right upper and lower heart chambers). It helps doctors understand if the lead causes leakage (regurgitation) over time.
This study compares newer pacemaker types to see how well they work and how they affect your heart's pumping ability and valve function over a short period. You'll be monitored closely with heart imaging to understand which pacemaker performs best.
This study looks back at patients who were successfully treated with TricValve bicaval valve devices and then follows up with their outcomes. You might join if you (or your legal guardian) agree to be included.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study looks at how the heart adjusts after a procedure to replace the tricuspid valve (the valve between the right upper and lower heart chambers). It focuses on patients who need medication to support their blood pressure within 24 hours after the procedure, to better understand and manage this unstable period.
This study looks at whether doing a tricuspid valve repair at the same time as left-heart valve surgery is helpful for people who have mild tricuspid valve leakage. It may reduce future valve problems, but your eligibility depends on your heart valve type and recent health history.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.